The Rise of Psychedelic Therapy

Riding the wave of medical cannabis legislation and research, new (or perhaps renewed) attention is being directed at the potential of psychedelic medicines. Psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and ketamine are just a few of the psychedelic substances already well into clinical trials.      With a global market predicted to reach anywhere …

The Rise of Psychedelic Therapy Read More »